PL 2018       
Pavel Levkin is head of the Biofunctional Materials research group at Karlsruhe Institute of Technology (KIT), Germany. He graduated from the Institute of Fine Chemical Technology, Moscow and obtained his Ph.D. in Organic Chemistry from the University of Tübingen in Germany, followed by postdoctoral work at the University of California, Berkeley. Pavel Levkin is the cofounder of ScreenFect GmbH and Aquarray GmbH. His research focuses on the development of functional and responsive materials, and surfaces for biomedical and biotechnological applications.
 

 

 


Education and Research Experience


 

Current position                        

Priv.-Doz.

 

 

Head of research group of Biofunctional Materials                                  
Karlsruhe Institute of Technology (KIT)
Institute of Toxicology and Genetics
und Institute of Organic Chemistry
 

 

 2009-present

 

 

 

   Habilitation in Organic Chemistry, KIT  2016
   Affiliation with Heidelberg University,
Applied Physical Chemistry, Prof. Grunze

 2009-2014

 

 Postdoc

 

 

 

University of California, Berkeley, USA

Group of Prof. J.M.J. Fréchet
and Dr. F. Svec
Polymer Chemistry

 2007-2009

 

 

 

Visiting scientist

 

University of Vienna, Austria

Group of Prof. Wolfgang Lindner

2006

 

Ph.D.

 

 

 

Chemistry (Summa Cum Laude)

University of Tübingen, Germany

Group of Prof. Volker Schurig
Organic and Analytical Chemistry

2003 – 2007

 

 

 

B.Sc. and M.Sc.

 

 

 

Chemistry and Chemical Engineering (with honors)
Institute of Chemical Physics, Russian Academy of Sciences

and Moscow Institute of Fine Chemical Technology
Group of Prof. Rem Kostyanovsky

1997 – 2003

 

 

 

 

 


Funding


2017-2019                         EXIST Forschungstransfer Grant 
2017  ERC Proof-of-Concept Grant, CellPrintArray
2015  ERC Proof-of-Concept Grant, CellScreenChip 
2014 

Helmholtz ERC-Prämie

2014-2018 ERC Starting Grant (DropCellArray-337077)
2012 Helmholtz-Sonderförderung Grant
2011 Helmholtz-Enterprise Grant
2010 Young Investigators Network Start-up grant
2009-2014 Helmholtz-University Young Investigator Group Grant
 

 


Reviewer


JACS, Nature Communication, Analytical Chemistry, Angewandte Chemie, Biointerphases, Chemical Communication, Journal of the Materials Chemistry, Nano Letters, Acta Biomaterialia, Advanced Functional Materials, Drug Research, Green Chemistry, Macromolecular Bioscience, Advanced Materials, Biomaterials, ACS Applied Materials and Interfaces, ACS Nano, Advanced Healthcare Materials, Langmuir, Advanced Materials Interfaces, Biomacromolecules, Drug Research, European Polymer Journal, Journal of Chromatography A, Journal of Separation Science, Macromolecular Bioscience, Macromolecular Rapid Communication, Science, Scientific Reports, Small

 

 


 On the Editorial Boards of


Advanced Biosystems (Wiley)
Horizon Materials Bio (Elsevier)
Advanced Functional Materials (Wiley)

 

 


Innovation


  • cofounder of ScreenFect GmbH (formerly Incella GmbH), founded in 2012, activities: lipid synthesis research, development and commerciallization of novel synthetic gene delivery vectors for biological and biomedical applications. ScreenFect transfection reagents are commerciallized worldwide and cited more than 115 times (2016).

 ScreenFect

  • cofounder of Aquarray GmbH, founded 29.03.2018, development and commerciallization of the novel miniaturized platform for cell experiments and personalized medicine.

 Aquarray

 


Awards


  • 2017; Aquarray projet wins Science4Life Venture Cup 2017, www.science4life.de/GewinnerProfil383.aspx
  • 2015; Heinz Meier-Leibnitz Prize for early career researchers in Germany awarded by the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF). Highlighted by DFG, Angewandte Chemie.
  • 2014; Ewald-Wicke Prize
  • 2014-2018; ERC Starting Grant. “DropletMicroarrays: Ultra High-Throughput Screening of Cells in 3D Microenvironments” (€1,5M);
  • 2012; 2018; Co-founder of ScreenFect GmbH and Aquarray GmbH, respectively
  • 2010-2014; Helmholtz-University Young Investigator Group Grant (€1,25M);
  • 2006; The Ernst-Bayer-Prize from the German Chemical Society (GDCh);
  • 2005, 2007; Poster awards at 17th and 19th ISCD, Italy and USA

Contact

Dr. Pavel Levkin   
Build.: 341 / Office: 154 
E-Mail: levkin@kit.edu
Tel:  +49-721-608-29175

KIT Adress

Karlsruhe Institute of Technology (Campus North)
Institute of Toxicology and Genetics - Geb. 341
Hermann-von-Helmholtz-Platz 1
76344 Eggenstein-Leopoldshafen, Germany

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

On this website we use cookies for a better die usability. If you click on other pages you you agree with this.

In some instances, our website and its pages use so-called cookies. Cookies do not cause any damage to your computer and do not contain viruses. The purpose of cookies is to make our website more user friendly, effective and more secure. Cookies are small text files that are placed on your computer and stored by your browser.

Most of the cookies we use are so-called “session cookies.” They are automatically deleted after your leave our site. Other cookies will remain archived on your device until you delete them. These cookies enable us to recognise your browser the next time you visit our website.

You can adjust the settings of your browser to make sure that you are notified every time cookies are placed and to enable you to accept cookies only in specific cases or to exclude the acceptance of cookies for specific situations or in general and to activate the automatic deletion of cookies when you close your browser. If you deactivate cookies, the functions of this website may be limited.

Cookies that are required for the performance of the electronic communications transaction or to provide certain functions you want to use (e.g. the shopping cart function), are stored on the basis of Art. 6 Sect. 1 lit. f GDPR. The website operator has a legitimate interest in storing cookies to ensure the technically error free and optimised provision of the operator’s services. If other cookies (e.g. cookies for the analysis of your browsing patterns) should be stored, they are addressed separately in this Data Protection Declaration.